Back to Search

ASHISH AWASTHI, M.D.

M.D.

Cardiovascular Disease Physician

NPI: 1033146618IndividualAccepts Medicare

Specialties, Licenses & Credentials

Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

25MA08091400(NJ)

CMS Specialties

PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)

Additional

PERIPHERAL VASCULAR DISEASE

Education

OTHER

Class of 1992

Research & Publications (20)

Non-toxic melanoma therapy by a novel tubulin-binding agent.
PMID 19626589·Int J Cancer·2010
7-preclinical
Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS).
PMID 19609837·AAPS PharmSciTech·2009
7-preclinical
IMCI approach in tertiary hospitals, India.
PMID 19381499·Indian J Pediatr·2009
4-observational
IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation.
PMID 19448657·Nat Immunol·2009
7-preclinical
Status of Stat3 in an ovalbumin-induced mouse model of asthma: analysis of the role of Socs3 and IL-6.
PMID 18799889·Int Arch Allergy Immunol·2009
7-preclinical
Mechanistic aspects of benzothiazepines: a class of antiarrhythmic drugs.
PMID 18407379·Eur J Med Chem·2009
8-other
High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats.
PMID 19362193·Talanta·2009
7-preclinical
A case of facial lymphoma mimicking dental infection.
PMID 19518035·Dent Update·2009
5-case
Th17 cells: from precursors to players in inflammation and infection.
PMID 19261692·Int Immunol·2009
6-review
Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells.
PMID 19414740·J Immunol·2009
7-preclinical
IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells.
PMID 19433802·Proc Natl Acad Sci U S A·2009
7-preclinical
Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells.
PMID 19570826·J Immunol·2009
7-preclinical
IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells.
PMID 19015529·Proc Natl Acad Sci U S A·2008
7-preclinical
Interplay between effector Th17 and regulatory T cells.
PMID 18810613·J Clin Immunol·2008
7-preclinical
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
PMID 18997793·Nat Immunol·2008
7-preclinical
Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells.
PMID 18548087·Genes Immun·2008
7-preclinical
Antibubble trajectory during embryo transfers in donor egg IVF does not predict success.
PMID 18549701·Reprod Biomed Online·2008
8-other
Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
PMID 18619980·Life Sci·2008
7-preclinical
Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity.
PMID 18714009·J Immunol·2008
7-preclinical
Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
PMID 18761148·Talanta·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
901 W MAIN ST STE 205, CN 5050
FREEHOLD, NJ 07728

Quick Facts

NPI
1033146618
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
34
Publications
20

Are you this provider?

Claim Your Profile